1. DNA Damage-Mediated Neurotoxicity in Parkinson’s Disease
   Zhong-Xuan Wang et al, 2023, International Journal of Molecular Sciences CrossRef
2. Nicotinamide Mononucleotide and Melatonin Alleviate Aging-induced Cognitive Impairment via Modulation of Mitochondrial Function and Apoptosis in the Prefrontal Cortex and Hippocampus
   Leila Hosseini et al, 2019, Neuroscience CrossRef
3. Metal Chelation Therapy and Parkinson’s Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs
   Marianna Tosato et al, 2019, Biomolecules CrossRef
4. Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson’s disease
   Yanhua Shen et al, 2020, Biomedicine & Pharmacotherapy CrossRef
5. Technology and functional insights into the nicotinamide mononucleotide for human health
   Ye Liu et al, 2023, Applied Microbiology and Biotechnology CrossRef
6. Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer’s disease-relevant murine model
   Aaron N Long et al, 2015, BMC Neurology CrossRef
7. NAD+ Metabolism and Diseases with Motor Dysfunction
   Samuel Lundt et al, 2021, Genes CrossRef
8. Food and Food Waste Antioxidants: Could They Be a Potent Defence against Parkinson’s Disease?
   Claudia Cannas et al, 2024, Antioxidants CrossRef
9. Preparation of a multiple interacting magnetic fluid for rapid and sensitive simultaneous extraction of β-nicotinamide mononucleotide metabolites in biological samples
   Yajie Zhang et al, 2024, Analytica Chimica Acta CrossRef
10. The versatile multi-functional substance NMN: its unique characteristics, metabolic properties, pharmacodynamic effects, clinical trials, and diverse applications
    Bin Yu et al, 2024, Frontiers in Pharmacology CrossRef
11. Protective effects of β- nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson's disease
    Chang Shan et al, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry CrossRef
12. Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism
    Annadurai Anandhan et al, 2017, Brain Research Bulletin CrossRef
13. Dietary supplementation for traumatic brain injury
    Muthu Kumaradoss MohanMarugaRaja et al, 2022, Diagnosis and Treatment of Traumatic Brain Injury CrossRef
14. Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway
    Theresa Grohmann et al, 2018, Leukemia Research CrossRef
15. Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3‐dependent mechanism in male mice
    Nina Klimova et al, 2019, Journal of Neuroscience Research CrossRef
16. Biosynthesis of β-nicotinamide mononucleotide from glucose via a new pathway in Bacillus subtilis
    Zhilei Tan et al, 2024, Frontiers in Microbiology CrossRef
17. Benefits of Vitamins in the Treatment of Parkinson’s Disease
    Xiuzhen Zhao et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
18. Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain
    Chidambaram Ramanathan et al, 2022, Nutrients CrossRef
19. Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism
    Weiqi Hong et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
20. Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors
    Jing She et al, 2021, Aging and disease CrossRef
21. PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease
    Jie Li et al, 2022, Cell Death & Disease CrossRef
22. Effects of lifespan-extending interventions on cognitive healthspan
    Luka Culig et al, 2023, Expert Reviews in Molecular Medicine CrossRef
23. Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns
    Harshani Nadeeshani et al, 2022, Journal of Advanced Research CrossRef
24. Nicotinamide Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice through Its Anti-Inflammatory Properties and Modulates the Gut Microbiota
    Kai Kang et al, 2021, Journal of Immunology Research CrossRef
25. Construction of Nicotinamide Mononucleotide-Loaded Liposomes and Their In Vitro Transport Across the Blood–Brain Barrier
    Tiantian Wang et al, 2024, Applied Sciences CrossRef
26. Toward understanding genomic instability, mitochondrial dysfunction and aging
    Nima B. Fakouri et al, 2019, The FEBS Journal CrossRef
27. Importance of Mitochondrial Quality Control in Parkinson’s Disease: The Potential Interplay of Mitochondrial Unfolded Protein Response and Mitophagy
    Yew Mun Lee et al, 2021, Oxidative Stress CrossRef
28. DMT1 differentially regulates mitochondrial complex activities to reduce glutathione loss and mitigate ferroptosis
    Qing Tan et al, 2023, Free Radical Biology and Medicine CrossRef
29. Progresses in both basic research and clinical trials of NAD+ in Parkinson’s disease
    María José Pérez et al, 2021, Mechanisms of Ageing and Development CrossRef
30. NAD + in Aging: Molecular Mechanisms and Translational Implications
    Evandro F. Fang et al, 2017, Trends in Molecular Medicine CrossRef
31. Mini-Review on Lipofuscin and Aging: Focusing on The Molecular Interface, The Biological Recycling Mechanism, Oxidative Stress, and The Gut-Brain Axis Functionality
    Ovidiu-Dumitru Ilie et al, 2020, Medicina CrossRef
32. The Role of Vitamins in Neurodegenerative Disease: An Update
    Sachchida Nand Rai et al, 2021, Biomedicines CrossRef
33. Subclavian steal syndrome decreases neurogenesis in the cerebellar cortex and affects cognitive function in rabbits
    XIAO-YANG FU et al, 2015, Experimental and Therapeutic Medicine CrossRef
34. Synthesis of functional oligosaccharides and their derivatives through cocultivation and cellular NTP regeneration
    Jianrong Wu et al, 2021, CrossRef
35. Sirtuins Modulation: A Promising Strategy for HIV-Associated Neurocognitive Impairments
    Izchel Figarola-Centurión et al, 2022, International Journal of Molecular Sciences CrossRef
36. NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity
    XIAO-DONG ZOU et al, 2016, Molecular Medicine Reports CrossRef
37. Perturbed Brain Glucose Metabolism Caused by Absent SIRT3 Activity
    Tibor Kristian et al, 2021, Cells CrossRef
38. Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects
    Bogdan Doroftei et al, 2020, Molecules CrossRef
39. Nicotinamide mononucleotide administration after sever hypoglycemia improves neuronal survival and cognitive function in rats
    Xiaonan Wang et al, 2020, Brain Research Bulletin CrossRef
40. Unraveling the Mechanisms of Hydrophilic Vitamins in Alzheimer’s and Parkinson’s: Preclinical and Clinical Evidence
    Stuti Parab et al, 2024, Hydrophilic Vitamins in Health and Disease CrossRef
41. Suitability of Banana and Plantain Fruits in Modulating Neurodegenerative Diseases: Implicating the In Vitro and In Vivo Evidence from Neuroactive Narratives of Constituent Biomolecules
    Barnabas Oluwatomide Oyeyinka et al, 2022, Foods CrossRef
42. Understanding the Molecular Aspects of Vitamins in Parkinson’s Disease: Present-day Concepts and Perspectives
    Tapan Behl et al, 2023, Current Pharmaceutical Design CrossRef
43. Role of mediterranean diet in Parkinson's disease
    Mohannad A. Almikhlafi et al, 2023, Diet and Nutrition in Neurological Disorders CrossRef